Melatonin antagonizes hypoxia-mediated glioblastoma cell migration and invasion via inhibition of HIF-1α

Journal of Pineal Research

Volumn 55, Issue 2, 2013, Pages 121-130

  Zhang, Yanmin ^a   Liu, Qian ^a   Wang, Fuwu ^a   Ling, Eng Ang ^b   Liu, Shangming ^a   Wang, Liyan ^a   Yang, Yang ^a   Yao, Linli ^a   Chen, Xueran ^a   Wang, Fen ^a   Shi, Wei ^a   Gao, Ming ^a   Hao, Aijun ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Glioblastoma multiforme; HIF 1 ; Hypoxia; Invasion; Melatonin; Migration

Indexed keywords

BETA ACTIN; GELATINASE A; GREEN FLUORESCENT PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MELATONIN; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; VASCULOTROPIN; HIF1A PROTEIN, HUMAN; MMP2 PROTEIN, HUMAN; VASCULOTROPIN A;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL HYPOXIA; CELL INVASION; CELL MIGRATION; CELL VIABILITY; GENE OVEREXPRESSION; GENE SILENCING; GLIOBLASTOMA; HUMAN; HUMAN CELL; HYDROXYLATION; PROTEIN EXPRESSION; TUMOR MICROENVIRONMENT; UBIQUITINATION; ANOXIA; ANTAGONISTS AND INHIBITORS; CELL MOTION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE; TUMOR INVASION;

ANOXIA; CELL LINE, TUMOR; CELL MOVEMENT; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MATRIX METALLOPROTEINASE 2; MELATONIN; NEOPLASM INVASIVENESS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885173431     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12052     Document Type: Article

References (50)

1. CLAES A, IDEMA AJ, WESSELING P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007; 114:443-458.
2. LEFRANC F, RYNKOWSKI M, DEWITTE O et al. Present and potential future adjuvant issues in high-grade astrocytic glioma treatment. Adv Tech Stand Neurosurg 2009; 34:3-35.
3. MELILLO G, SEMENZA GL. Meeting report: exploiting the tumor microenvironment for therapeutics. Cancer Res 2006; 66:4558-4560.
4. LIAO D, JOHNSON RS. Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007; 26:281-290.
5. JENSEN RL. Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target. J Neurooncol 2009; 92:317-335.
6. HOCKEL M, SCHLENGER K, ARAL B et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996; 56:4509-4515.
7. SOEDA A, PARK M, LEE D et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009; 28:3949-3959.
8. YU F, WHITE SB, ZHAO Q et al. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci USA 2001; 98:9630-9635
9. IVAN M, KONDO K, YANG H et al. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 2001; 292:464-468.
10. JAAKKOLA P, MOLE DR, TIAN YM et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472.
11. CHAN DA, SUTPHIN PD, YEN SE et al. Coordinate regulation of the oxygen-dependent degradation domains of hypoxiainducible factor 1 alpha. Mol Cell Biol 2005; 25:6415-6426.
12. CHAN DA, SUTPHIN PD, DENKO NC et al. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002; 277:40112-40117.
13. BAR EE, LIN A, MAHAIRAKI V et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 2010; 177: 1491-1502.
14. MASHIKO R, TAKANO S, ISHIKAWA E et al. Hypoxia-inducible factor 1alpha expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image. J Neurooncol 2011; 102:43-50.
15. LEE OH, XU J, FUEYO J et al. Angiopoietin-2 decreases vascular endothelial growth factor expression by modulating HIF-1 alpha levels in gliomas. Oncogene 2008; 27:1310-1314.
16. KRISHNAMACHARY B, BERG-DIXON S, KELLY B et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63:1138-1143.
17. MUNOZ-NAJAR UM, NEURATH KM, VUMBACA F et al. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 2006; 25:2379 -2392.
18. GONDI CS, LAKKA SS, DINH DH et al. Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth. Neuron Glia Biol 2004; 1:165-176.
19. LANOIX D, BEGHDADI H, LAFOND J et al. Human placental trophoblasts synthesize melatonin and express its receptors. J Pineal Res 2008; 45:50-60.
20. VENEGAS C, GARCIA JA, ESCAMES G et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52:217-227.
21. GAO C, HAN HB, TIAN XZ et al. Melatonin promotes embryonic development and reduces reactive oxygen species in vitrified mouse 2-cell embryos. J Pineal Res 2012; 52:305-311.
22. WU CC, LU KC, LIN GJ et al. Melatonin enhances endogenous heme oxygenase-1 and represses immune responses to ameliorate experimental murine membranous nephropathy. J Pineal Res 2012; 52:460-469.
23. MAURIZ JL, COLLADO PS, VENEROSO C et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54:1-14
24. KIM KJ, CHOI JS, KANG I et al. Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model. J Pineal Res 2013; 54:264-270.
25. VIJAYALAXMI BY, THOMAS CR Jr, REITER RJ et al. Melatonin: from basic research to cancer treatment clinics. J Clin Oncol 2002; 20:2575-2601.
26. LIU Y, ZHANG L, ZHANG H et al. Exogenous melatonin modulates apoptosis in the mouse brain induced by high-LET carbon ion irradiation. J Pineal Res 2012; 52:47-56.
27. MAO L, YUAN L, SLAKEY LM et al. Inhibition of breast cancer cell invasion by melatonin is mediated through regulation of the p38 mitogen-activated protein kinase signaling pathway. Breast Cancer Res 2010; 12:R107.
28. ORTIZ-LOPEZ L, MORALES-MULIA S, RAMIREZ-RODRIGUEZ G et al. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res 2009; 46:15-21.
29. WANG J, HAO H, YAO L et al. Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells. J Pineal Res 2012; 53:180-187.
30. WARNECKE C, ZABOROWSKA Z, KURRECK J et al. Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 2004; 18:1462-1464.
31. YANG CS, LEE HM, LEE JY et al. Reactive oxygen species and p47phox activation are essential for the Mycobacterium tuberculosis-induced pro-inflammatory response in murine microglia. J Neuroinflammation 2007; 4:27.
32. ZHANG X, YU H, LOU JR et al. MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells. J Biol Chem 2011; 286:1429-1435.
33. ZHANG Y, HAO H, ZHAO S et al. Downregulation of GRIM- 19 promotes growth and migration of human glioma cells. Cancer Sci 2011; 102:1991-1999.
34. SEMENZA GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci 2012; 33:207-214.
35. GALANO A, TAN DX, REITER RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51:1-16.
36. GALANO A, TAN DX, REITER R. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54:245-257.
37. FURNARI FB, FENTON T, BACHOO RM et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 2007; 21:2683-2710.
38. HARRIS AL. Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2:38-47.
39. COS S, FERNANDEZ R, GUEZMES A et al. Influence of melatonin on invasive and metastatic properties of MCF-7 human breast cancer cells. Cancer Res 1998; 58:4383-4390.
40. ZAGZAG D, ZHONG H, SCALZITTI JM et al. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 2000; 88:2606-2618.
41. ZAGZAG D, NOMURA M, FRIEDLANDER DR et al. Geldanamycin inhibits migration of glioma cells in vitro: a potential role for hypoxia-inducible factor (HIF-1alpha) in glioma cell invasion. J Cell Physiol 2003; 196:394-402.
42. ALQAWI O, MOGHADDAS M, Singh, G. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells. Prostate Cancer Prostatic Dis 2006; 9: 126-135.
43. BLAZQUEZ C, SALAZAR M, CARRACEDO A et al. Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase- 2 expression. Cancer Res 2008; 68:1945-1952.
44. SWARNAKAR S, PAUL S, SINGH LP et al. Matrix metalloproteinases in health and disease: regulation by melatonin. J Pineal Res 2011; 50:8-20.
45. GUO P, IMANISHI Y, CACKOWSKI FC et al. Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma. Am J Pathol 2005; 166: 877-890.
46. ROSKOSKI R Jr. Vascular endothelial growth factor (VEGF) signaling in tumor progression. Crit Rev Oncol Hematol 2007; 62:179-213.
47. HLOBILKOVA A, EHRMANN J, KNIZETOVA P et al. Analysis of VEGF, Flt-1, Flk-1, nestin and MMP-9 in relation to astrocytoma pathogenesis and progression. Neoplasma 2009; 56: 284-290.
48. CHANDEL NS, MALTEPE E, GOLDWASSER E et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 1998; 95:11715-11720.
49. PARK SY, JANG WJ, YI EY et al. Melatonin suppresses tumor angiogenesis by inhibiting HIF-1alpha stabilization under hypoxia. J Pineal Res 2010; 48:178-184.
50. KAUR B, KHWAJA FW, SEVERSON EA et al. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 2005; 7:134-153.